EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Expanding molecular and clinical spectrum of CPT1C ‐associated hereditary spastic paraplegia ( SPG73 )—a case series

Alexandra K Brooks iD, Vicente Quiroz, Luca Schierbaum, Amy Tam iD, Julian E Alecu, Darius Ebrahimi-Fakhari iD

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.52288 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Alexandra K Brooks und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Movement Disorders Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Carnitine O-Palmitoyltransferase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boston Children's Hospital Translational Research Program, Deutsche Forschungsgemeinschaft, International Parkinson and Movement Disorder Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal‐dominant variants in the CPT1C gene have been associated with hereditary spastic paraplegia type 73 (SPG73), which typically presents with slowly progressive lower limb weakness and spasticity and is therefore considered a pure form of hereditary spastic paraplegia. However, we report two unrelated males with novel CPT1C variants (NM_001199753.2: patient 1: c.2057_2061del (p.Ile686SerfsTer8) and patient 2: c.2020‐1G>C (p.?)) who presented with lower limb spasticity at 4 and 3 years old, respectively. Both patients also experienced significant cognitive impairment, seizures, or neurobehavioral symptoms. These cases illustrate a broader and more complex clinical spectrum of SPG73, extending beyond the traditionally recognized pure motor symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spastic Paraplegia, HereditaryCarnitine O-PalmitoyltransferaseHumansMaleChild, PreschoolCognitive Dysfunction

Substanzen

Carnitine O-Palmitoyltransferase

Autor:innen und Institutionen

  • Department of Neurology, Movement Disorders Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of General Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Alexandra K Brooks, Amy Tam, Darius Ebrahimi-Fakhari

Förderung

  • Boston Children's Hospital Translational Research Program
  • Deutsche Forschungsgemeinschaft
  • International Parkinson and Movement Disorder Society
  • NINDS NIH HHS
  • Spastic Paraplegia Foundation
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Brooks, A. K., Quiroz, V., Schierbaum, L., Tam, A., Alecu, J. E., & Ebrahimi-Fakhari, D. (2025). Expanding molecular and clinical spectrum of CPT1C ‐associated hereditary spastic paraplegia ( SPG73 )—a case series. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52288

Vancouver

Brooks AK, Quiroz V, Schierbaum L, Tam A, Alecu JE, Ebrahimi-Fakhari D. Expanding molecular and clinical spectrum of CPT1C ‐associated hereditary spastic paraplegia ( SPG73 )—a case series. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.52288

BibTeX
@article{Brooks2025,
  author = {Brooks, Alexandra K and Quiroz, Vicente and Schierbaum, Luca and Tam, Amy and Alecu, Julian E and Ebrahimi-Fakhari, Darius},
  title = {Expanding molecular and clinical spectrum of CPT1C ‐associated hereditary spastic paraplegia ( SPG73 )—a case series},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.52288}
}
Kostenlos starten →